Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 23 von 26
Anticancer research, 1999-07, Vol.19 (4B), p.3141
1999
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Quantification of apoptosis induction by doxorubicin in three types of human mammary carcinoma spheroids
Ist Teil von
  • Anticancer research, 1999-07, Vol.19 (4B), p.3141
Ort / Verlag
Greece
Erscheinungsjahr
1999
Quelle
MEDLINE
Beschreibungen/Notizen
  • Apoptosis, also termed programmed cell death, is an active form of cellular degradation in contrast to the passive, inflammatory necrosis. Triggering apoptosis in tumor cells is a significant aim of chemotherapeutic treatment. In this investigation the rate of apoptosis in human mammary carcinoma cell spheroids and monolayers was quantified following treatment with doxorubicin using various concentrations and incubation times. These data were compared with results of standardized clonogenicity assays, spheroid volume growth curves, and flowcytometric cell cycle analysis and BrdU-labeling. Whereas spheroid volume growth and cellular clonogenicity were in excellent accordance with the well-established chemosensitivity of the three cell lines, the incidence of apoptosis did not reflect the different susceptibility of the cell lines to doxorubicin in a systematic way. On the other hand, theoretical considerations showed that the relatively low proportion of apoptosis can account for the relatively large decrease in spheroid volume, as observed in doxorubicin-treated T47D spheroids. The experimental data suggest that suppression of apoptosis is not an obligatory feature of multi-drug resistant cell lines, and that resistance is rather correlated with an increase in DNA-synthesis.
Sprache
Englisch
Identifikatoren
ISSN: 0250-7005
Titel-ID: cdi_pubmed_primary_10652603

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX